Tuesday 24th January 2012 |
Text too small? |
The liquidator for the Blue Chip group of companies has filed a $40 million claim against the failed property investment group, which banked investors’ funds straight into its own bank accounts instead of into trust accounts.
The statement of claim, lodged in the High Court in Auckland, is against Blue Chip’s former directors and auditors, and on behalf of about 800 investors, liquidator Jeff Meltzer of Meltzer Mason Heath said in a statement.
The suit focuses on the post-2006 period, when Blue Chip sold apartments off development plans in Auckland’s central business district, and alleges there were “inherent flaws” in the business model which led to its collapse.
“These inherent flaws were compounded by the way the business model was operated,” Meltzer said. “Rather than purchasers’ deposits being held in a solicitor’s trust account, they were instead paid to Blue Chip.”
Former Blue Chip boss Mark Bryers faces indefinite bankruptcy in New Zealand after the Official Assignee lodged an objection against discharging him.
He was bankrupted in 2009 after his Blue Chip scheme started falling over.
The liquidators said they have been working on recoveries for investors through civil action, and today’s step was the first in what may be a lengthy process.
Bryers escaped a prison sentence in 2010 when he pleaded guilty to 34 charges relating to the company’s mismanagement and improper accounting, angering more than 2,000 investors owed some $84 million who saw his punishment of a $33,750 fine and 75 hours' community work as inadequate.
The group was probed by the Serious Fraud Office, though the white-collar crime investigator decided there was insufficient evidence to pursue a prosecution, even if it operated in a “moral vacuum”.
Bryers has been earning a living in Australia, advising on apparently similar schemes to Blue Chip.
(BusinessDesk)
BusinessDesk.co.nz
No comments yet
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report